Saturated fatty acids linked to breast cancer in postmenopausal women

June 07, 2016

OAK BROOK, Ill. - Fatty acids in the breast may be useful indicators of cancer in postmenopausal women, according to a new study published online in the journal Radiology. The results may help researchers determine the underlying mechanisms behind breast cancer development in some patients.

The role of fat in breast cancer development and growth has been studied extensively using body mass index (BMI) and dietary fat intake.

"BMI is an important risk factor for breast cancer development," said Sungheon G. Kim, Ph.D., from the NYU Langone Medical Center. "While increased BMI may provide a protective effect for premenopausal women, postmenopausal women have an increased risk of developing breast cancer with increasing BMI."

The exact mechanism behind the increased risk in postmenopausal women with higher BMI is not fully understood. One possibility is the increased production of estrogen and/or adipokines, which are cell-signaling proteins secreted by adipose, or fat, tissue, but there have been few studies specifically looking at the role of breast fat in cancer development.

"Using a new method, we were able to directly measure the tissue where breast cancer begins in the hopes of understanding how fatty tissue correlates with cancer," said Melanie Freed, Ph.D., lead researcher of the study.

Researchers at the NYU Langone Medical Center developed a novel MRI method called gradient-echo spectroscopic imaging that can estimate fractions of different types of fat in breast adipose tissue as a part of clinical breast MRI exam.

Eighty-nine patients were included in the final analysis. Each patient's height and weight was measured at the time of the exam and their BMI was calculated. Fifty-eight women were premenopausal and 31 were postmenopausal. Breast cancer status was determined by a review of the patients' electronic medical record including any follow up procedures. Forty-nine patients had benign breast tissue, 12 had ductal carcinoma in situ, and 28 had invasive ductal carcinoma.

The results showed that a greater proportion of saturated fatty acids and a lower proportion of monounsaturated fatty acids were present in the breast tissue of postmenopausal women with invasive ductal carcinoma than in postmenopausal women with benign breast tissue.

Among the women with benign lesions, postmenopausal women had significantly higher polyunsaturated fatty acids and lower saturated fatty acids in their breasts than premenopausal women.

Research showed no correlation between BMI and fatty acid fractions in breast tissue, suggesting that the type of fat that makes up fatty breast tissue gives new information beyond the amount of overall body fat.

"Our research is ongoing," Dr. Kim said. "We need to investigate these higher levels of saturated fat and their direct correlation with tissue estrogen levels and cancer development. The results may point to a new risk factor for breast cancer."
-end-
"Evaluation of Breast Lipid Composition in Patients with Benign Tissue and Cancer by Using Multiple Gradient-Echo MR Imaging." Collaborating with Drs. Kim and Freed were Pippa Storey, Ph.D., Alana Amarosa Lewin, M.D., James Babb, Ph.D., Melanie Moccaldi, R.T., and Linda Moy, M.D.

Radiology is edited by Herbert Y. Kressel, M.D., Harvard Medical School, Boston, Mass., and owned and published by the Radiological Society of North America, Inc. (http://radiology.rsna.org/)

RSNA is an association of more than 54,000 radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)

For patient-friendly information on breast MRI, visit RadiologyInfo.org.

Radiological Society of North America

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.